Infections in acute exacerbation of chronic bronchitis: what are they and how do we know?

R P Baughman1, E Pina

  • 1Division of Pulmonary and Critical Care Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0564, USA.

Insights

Bacterial infections are a common cause of acute exacerbations of chronic bronchitis (AECB). Diagnostic methods like sputum examination and protected brush specimens help identify pathogens such as H. influenzae, S. Pneumoniae, and B. catarrhalis.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Acute exacerbations of chronic bronchitis (AECB) are frequently triggered by infections.
  • Bacterial infections account for approximately 50% of AECB cases.
  • Identifying causative pathogens is crucial for effective treatment.

Purpose of the Study:

  • To review diagnostic methods for identifying bacterial pathogens in AECB.
  • To highlight common pathogens implicated in AECB.
  • To emphasize the role of diagnostics in guiding treatment strategies.

Main Methods:

  • Sputum examination as a primary diagnostic tool.
  • Invasive techniques including transtracheal aspirates.
  • Bronchoscopic sampling, with a focus on the protected brush specimen (PBS).

Main Results:

  • Commonly identified pathogens include Haemophilus influenzae, Streptococcus pneumoniae, and Branhamella catarrhalis.
  • Gram-negative enteric organisms are observed in patients with advanced disease.
  • Diagnostic studies provide essential information for treatment development.

Conclusions:

  • Consistent identification of key bacterial pathogens across various diagnostic methods.
  • Diagnostic information is vital for updating treatment guidelines for AECB.
  • Ongoing surveillance of bacterial resistance patterns is necessary for optimal patient care.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...